)
Nordhealth (NORDH) investor relations material
Nordhealth Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 revenue was €15.2m, up 17.5% YoY; recurring revenue rose 17.0% to €13.5m, accelerating from 14.6% growth in Q2.
Signed ARR reached €53.1m; implemented ARR grew 13.5% YoY, with €3.2m signed but awaiting implementation.
Veterinary and therapy growth continued; FY2026 guidance is expected toward the top end, with profitability improving.
Financial highlights
Q3 recurring revenue was €13.5m versus €11.5m in Q3 2025; other revenue was €1.7m. Recurring revenue represented 88.6% of total revenue versus 89.0%.
YTD revenue rose 11.9% YoY to €42.8m; recurring revenue was €38.7m, up 14.3%, and represented 90.3% of revenue versus 88.4%.
Q3 adjusted EBITDA was €2.5m versus €0.9m; adjusted EBITDA-CapEx was positive €1.3m versus negative €0.2m.
YTD adjusted EBITDA was €2.7m versus €1.4m; adjusted EBITDA-CapEx was negative €0.9m versus negative €2.0m. YTD net loss was €11.0m versus €7.9m.
YTD adjusted cash flow was negative €0.7m, improving €0.9m YoY; €0.2m of working-capital timing explained the difference from the EBITDA-CapEx improvement.
Outlook and guidance
FY2026 recurring revenue guidance is €50m–€53m, excluding acquisitions; management expects performance toward the top end, with the Q3 run-rate implying €52.2m.
FY2026 adjusted EBITDA-CapEx guidance is negative €4m to negative €1m, excluding acquisitions; management expects the top end or a slight outperformance.
Most Aspit users are targeted to migrate by year-end, with migration continuing into next year depending on customer readiness and feedback.
Q4 results and FY2027 guidance are scheduled for March 2, 2027; gross margin is expected to improve, with no target level given.
- ARR up 12.5% to €52.1M, strong retention, and 2027+ profitability on track.NORDH
Q2 & CMD 2026 - Q1 2026 revenue up 7.9% with double-digit ARR growth and strong cloud and AI expansion.NORDH
Q1 2026 - 2025 revenue surpassed EUR 50 million, driven by strong recurring and cloud ARR growth.NORDH
Q4 2025 - Q3 2025 revenue rose 15.2%, with strong ARR, robust cash, and ongoing R&D investment.NORDH
Q3 2025 - H1 2025 recurring revenue up 17% to €22.3M; ARR up 9.5% to €42.3M.NORDH
Q2 2025 - Strong Q3 with 23.7% ARR growth, higher guidance, and improved profitability.NORDH
Q3 2024 - Q2 2024 saw 33% revenue growth, positive EBITDA, and robust ARR expansion in Veterinary.NORDH
Q2 2024 - Q1 2025 revenue rose 23% with ARR up 21.5%, led by strong retention and cloud migration.NORDH
Q1 2025 - 20.5% ARR and 24% revenue growth in 2024, with 2025 focused on migrations and AI launches.NORDH
Q4 2024
Next Nordhealth earnings date
Next Nordhealth earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)